Detection of tumor-specific DNA in blood
β
Heidi Schwarzenbach; Felix K.-H. Chun; Imke Lange; Sebastian Carpenter; Miriam G
π
Article
π
2007
π
John Wiley and Sons
π
French
β 605 KB
## Abstract Tumor tissues, blood plasma and bone marrow (BM) aspirates of 57 prostate cancer patients (PCa) without clinical signs of overt metastases were assessed for LOH (loss of heterozygosity) by a PCRβbased fluorescence microsatellite analysis, using a panel of 15 markers. Additionally, micro